Cargando…
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
Incubation of umbilical cord blood (UCB) derived regulatory T-cells (Tregs) with fucosyltransferase enzyme improves their ability to home to the target tissue to prevent graft vs. host disease (GVHD). We report results of 5 patients (Double UCB Transplant, n=2; Peripheral Blood Matched Unrelated Don...
Autores principales: | Kellner, Joshua N., Delemarre, Eveline M., Yvon, Eric, Nierkens, Stefan, Boelens, Jaap J., McNiece, Ian, Olson, Amanda, Nieto, Yago, Ciurea, Stefan, Popat, Uday, Ahmed, Sairah, Champlin, Richard, Ramos, Jennifer, Nishimoto, Mitsutaka, Ma, Hongbing, Ke, Zeng, Thall, Peter, Khoury, Joseph D., Negrin, Robert, Andersson, Borje, Parmar, Simrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235025/ https://www.ncbi.nlm.nih.gov/pubmed/30479692 http://dx.doi.org/10.18632/oncotarget.26242 |
Ejemplares similares
-
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation
por: Andersson, Borje S., et al.
Publicado: (2022) -
Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan
por: Nieto, Yago, et al.
Publicado: (2017) -
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning in allogeneic stem cell transplantation
por: Konopleva, Marina, et al.
Publicado: (2015) -
ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells
por: Valdez, Benigno C., et al.
Publicado: (2022) -
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen
por: Kellner, Joshua N., et al.
Publicado: (2018)